Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | Solactive ISS ESG Nordic Investable Universe Net Zero Pathway |
| Investment focus | Actions, Europe, Social/durable |
| Fund size | EUR 123 m |
| Total expense ratio | 0,15% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Strategy risk | Long-only |
| Sustainability | Oui |
| Fund currency | EUR |
| Currency risk | Currency unhedged |
| Volatility 1 year (in EUR) | 16,86% |
| Inception/ Listing Date | 12 avril 2023 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Irlande |
| Fund Provider | Xtrackers |
| Fund Structure | Open-ended Investment Company (OEIC) |
| UCITS compliance | Yes |
| Administrator | State Street Custodial Services (Ireland) Limited |
| Investment Advisor | DWS Investments UK Limited |
| Custodian Bank | State Street Custodial Services (Ireland) Limited, Dublin 2 |
| Revision Company | Pricewaterhouse Coopers |
| Fiscal Year End | 31 décembre |
| Swiss representative | DWS CH AG |
| Swiss paying agent | Deutsche Bank (Suisse) SA |
| Germany | 30% d’exonération partielle |
| Switzerland | Pas d’ESTV Reporting |
| Austria | Meldefonds |
| UK | UK Reporting |
| Indextype | - |
| Swap counterparty | - |
| Collateral manager | |
| Securities lending | No |
| Securities lending counterparty |
| Novo Nordisk | 6,35% |
| Investor | 3,91% |
| Novonesis Novozymes | 3,13% |
| DSV A/S | 3,03% |
| Assa Abloy | 2,27% |
| Genmab | 2,26% |
| Zealand Pharma | 2,13% |
| Lifco | 2,09% |
| Danske Bank | 2,08% |
| Mycronic | 2,00% |
| Suède | 48,04% |
| Danemark | 25,91% |
| Finlande | 7,21% |
| Norvège | 7,04% |
| Industrie | 20,97% |
| Services financiers | 17,51% |
| Santé | 16,31% |
| Immobilier | 10,73% |
| Autre | 34,48% |
| YTD | -2.22% |
| 1 month | -4.35% |
| 3 months | +2.95% |
| 6 months | -0.70% |
| 1 year | -7.84% |
| 3 years | - |
| 5 years | - |
| Since inception (MAX) | +11.31% |
| 2025 | +0.82% |
| 2024 | +4.00% |
| 2023 | - |
| 2022 | - |
| Volatility 1 year | 16.86% |
| Volatility 3 years | - |
| Volatility 5 years | - |
| Return per risk 1 year | -0.32 |
| Return per risk 3 years | - |
| Return per risk 5 years | - |
| Maximum drawdown 1 year | -20.93% |
| Maximum drawdown 3 years | - |
| Maximum drawdown 5 years | - |
| Maximum drawdown since inception | -23.88% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | XNZN | - - | - - | - |
| London Stock Exchange | GBP | XNZN | XNZN LN XNZNEUIV | XNZN.L I2S2INAV.DE | |
| XETRA | EUR | XNZN | XNZN GR XNZNGBIV | XNZN.DE I2S4INAV.DE |
| Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
|---|---|---|---|---|
| UBS MSCI EMU Socially Responsible UCITS ETF EUR dis | 828 | 0.20% p.a. | Distributing | Full replication |
| Amundi MSCI EMU ESG Broad Transition UCITS ETF Dist | 127 | 0.12% p.a. | Distributing | Full replication |
| HSBC Europe Ex UK Screened Equity UCITS ETF EUR (Dist) | 34 | 0.15% p.a. | Distributing | Full replication |